z-logo
Premium
Blinded continuous information monitoring of recurrent event endpoints with time trends in clinical trials
Author(s) -
Mütze Tobias,
Salem Susanna,
Benda Norbert,
Schmidli Heinz,
Friede Tim
Publication year - 2020
Publication title -
statistics in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.996
H-Index - 183
eISSN - 1097-0258
pISSN - 0277-6715
DOI - 10.1002/sim.8702
Subject(s) - negative binomial distribution , statistics , event (particle physics) , binomial distribution , count data , sample size determination , computer science , constant (computer programming) , econometrics , type i and type ii errors , poisson distribution , mathematics , physics , quantum mechanics , programming language
Blinded sample size re‐estimation and information monitoring based on blinded data has been suggested to mitigate risks due to planning uncertainties regarding nuisance parameters. Motivated by a randomized controlled trial in pediatric multiple sclerosis (MS), a continuous monitoring procedure for overdispersed count data was proposed recently. However, this procedure assumed constant event rates, an assumption often not met in practice. Here we extend the procedure to accommodate time trends in the event rates considering two blinded approaches: (a) the mixture approach modeling the number of events by a mixture of two negative binomial distributions and (b) the lumping approach approximating the marginal distribution of the event counts by a negative binomial distribution. Through simulations the operating characteristics of the proposed procedures are investigated under decreasing event rates. We find that the type I error rate is not inflated relevantly by either of the monitoring procedures, with the exception of strong time dependencies where the procedure assuming constant rates exhibits some inflation. Furthermore, the procedure accommodating time trends has generally favorable power properties compared with the procedure based on constant rates which stops often too late. The proposed method is illustrated by the clinical trial in pediatric MS.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here